EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Sporothrix brasiliensis: Epidemiology, Therapy, and Recent Developments

Melissa Orzechowski Xavier iD, Vanice Rodrigues Poester iD, Mariana Rodrigues Trápaga, David A Stevens

Journal of Fungi · 13.09.2023 · 9 (9) · 921

DOI: 10.3390/jof9090921 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Fungi, online erschienen am 13.09.2023. Verfasst von Melissa Orzechowski Xavier und 3 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Pós-Graduação em Ciências da Saúde, Faculdade de Medicina (FAMED), Universidade Federal do Rio Grande (FURG), Rio Grande 96200-190, RS, B…. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sporotrichosis caused by Sporothrix brasiliensis is an emergent mycosis that is now a worldwide concern. One important step to sporotrichosis control is its correct treatment. However, limitations abound; thus, new antifungals, mainly focused on S. brasiliensis, are urgently needed. We performed a systematic review (following the PRISMA guideline) focused on (1) the global distribution of human and animal sporotrichosis by S. brasiliensis, especially outside of Brazil; (2) appraising therapies tested against this pathogen. We identified sporotrichosis caused by S. brasiliensis reported in five countries (Paraguay, Chile, Argentina, the United Kingdom, and the United States) in addition to Brazil, occurring on three continents, highlighting the epidemiological scenario in Argentina with an important increase in reported cases in recent years. Regarding the antifungal activity of drugs, 25 articles described the in vitro action of 20 unique chemicals and eight repurposed drugs against S. brasiliensis. Only five studies reported in vivo activity against S. brasiliensis (five drugs) using invertebrate and vertebrate models. Sporotrichosis caused by S. brasiliensis has a global impact and it is no longer specifically a Brazilian problem. We review the need for understanding the disease epidemiology, education of clinicians and of the populace, organization of health care delivery to respond to a spreading epidemic, and research on therapy for sporotrichosis.

Schlagwörter

Stichwörter der Autor:innen

antifungalcatsdrugssporotrichosissubcutaneous mycosiszoonosis

Autor:innen und Institutionen

  • Programa de Pós-Graduação em Ciências da Saúde, Faculdade de Medicina (FAMED), Universidade Federal do Rio Grande (FURG), Rio Grande 96200-190, RS, Brazil.
  • Laboratório de Micologia, Faculdade de Medicina (FAMED), Universidade Federal do Rio Grande (FURG), Rio Grande 96200-190, RS, Brazil.
  • California Institute for Medical Research, San Jose, CA 95128, USA.
  • Division of Infectious Diseases and Geographic Medicine, Stanford University Medical School, Stanford, CA 94305, USA.

ORCID-Profile: Melissa Orzechowski Xavier, Vanice Rodrigues Poester

Zitieren

APA

Xavier, M. O., Poester, V. R., Trápaga, M. R., & Stevens, D. A. (2023). Sporothrix brasiliensis: Epidemiology, Therapy, and Recent Developments. Journal of Fungi, 9(9), 921. https://doi.org/10.3390/jof9090921

Vancouver

Xavier MO, Poester VR, Trápaga MR, Stevens DA. Sporothrix brasiliensis: Epidemiology, Therapy, and Recent Developments. Journal of Fungi. 2023;9(9):921. doi:10.3390/jof9090921

BibTeX
@article{Xavier2023,
  author = {Xavier, Melissa Orzechowski and Poester, Vanice Rodrigues and Trápaga, Mariana Rodrigues and Stevens, David A},
  title = {Sporothrix brasiliensis: Epidemiology, Therapy, and Recent Developments},
  journal = {Journal of Fungi},
  year = {2023},
  volume = {9},
  number = {9},
  pages = {921},
  doi = {10.3390/jof9090921}
}
Kostenlos starten →